A new model of risk: Implications of increasing pulse pressure and systolic blood pressure on cardiovascular disease

Journal of Hypertension, Supplement

Volumn 17, Issue 5, 1999, Pages

  Alderman, Michael H ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Cardiovascular disease; Pulse pressure; Systolic blood pressure

Indexed keywords

BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR DISEASE; DISEASE COURSE; HUMAN; PATHOPHYSIOLOGY; PROGNOSIS; PULSE RATE; REVIEW; RISK ASSESSMENT; RISK FACTOR;

BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; CARDIOVASCULAR DISEASES; DISEASE PROGRESSION; HUMANS; PROGNOSIS; PULSE; RISK ASSESSMENT; RISK FACTORS;

EID: 0033252953     PISSN: 09521178     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. MacMahon S, Peto R, Cutler J, Collins R, Sorlie P, Neaton J, et al. Blood pressure, stroke, and coronary heart disease. Lancet 1990; 335:765-774.
2. Collins R, Peto R, MacMahon S, Hebert P, fiebach NH, Eberlein KA, et al. Blood pressure, stroke, and coronary heart disease. Part 2. Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 1990; 335:827-838.
3. Medical Research Council Working Party. MRC Trial of treatment of mild hypertension: principal results. BMJ 1985; 291:97-104.
4. Hypertension Detection and Follow-Up Program Cooperative Group. Five-year findings of the Hypertension Detection and Follow-Up Program I. Reduction in mortality in persons with high blood pressure, including mild hypertension. JAMA 1979; 242:2562-2571.
5. Eastern Stroke and Coronary Heart Disease Collaborative Research Group. Blood pressure, cholesterol, and stroke in eastern Asia. Lancet 1998; 352:1801-1807.
6. Hansson L, Zanchetti A, Carruthers S, Dahlof B, Elmfeldt D, Julius S. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principle results of the Hypertension Optimal Treatment (HOT) randomised trial, Lancet 1998; 351:1755-1762.
7. Wiklund I, Hailing K, Ryden-Bergsten T, Fletcher A on behalf of the HOT Study Group. Does lowering the blood pressure improve the mood? Quality of life results from the hypertension optimal treatment (HOT) study. Blood Press 1997;6:357-364.
8. The Treatment of Mild Hypertension Research Group. The Treatment of Mild Hypertension Study: a randomized, placebo-controlled trial of a nutritional-hygienic regimen along with various drug monotherapies. Arch Intern Med 1991; 151:1413-1423.
9. Silagy CA, McNeil JJ. Epidemiological aspects of isolated systolic hypertension and implications for future research. Am J Cardiol 1992; 69:213-218.
10. Madhaven S, Ooi W, Cohen H, Alderman, M. Relation of pulse pressure and blood pressure reduction to the incidence of myocardial infarction. Hypertension 1994; 23:395-401.
11. Sleight P. Blood pressures, hearts, and U-shaped curves. (Letter) Lancet 1988; i:235.
12. Levy D. The role of systolic blood pressure in determining risk for cardiovascular disease. J Hypertens 1999; 17(Suppl. 1):S15-S18.
13. Franklin SS, Gustin W, Wong ND, Larson MG, Weber MA, Kannel WB, Levy D. Hemodynamic patterns of age-related changes in blood pressure: the Framingham Heart Study. Circulation 1997; 96:303-315.
14. Neaton JD, Wentworth D. Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease: overall findings and differences by age for 316 099 white men: Multiple Risk Factor Intervention Trial (MRFIT). Arch Intern Med 1992; 152:56-64.
15. Stamler J, Stamler R, Neaton J. Blood pressure, systolic and diastolic, and cardiovascular risks. Arch Intern Med 1993; 153:598-615.
16. Alderman M, Cohen H, Madhaven S. Distribution and determinants of cardiovascular events during 20 years of successful antihypertensive treatment. J Hypertens 1998; 16:761-769.